Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/curb-on-over-the-counter-sale-of-92-antibiotics-soon-kounteya-sinha-16934/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/curb-on-over-the-counter-sale-of-92-antibiotics-soon-kounteya-sinha-16934/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/curb-on-over-the-counter-sale-of-92-antibiotics-soon-kounteya-sinha-16934/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/curb-on-over-the-counter-sale-of-92-antibiotics-soon-kounteya-sinha-16934/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802f7208ebc0-trace').style.display = (document.getElementById('cakeErr6802f7208ebc0-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6802f7208ebc0-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802f7208ebc0-code').style.display = (document.getElementById('cakeErr6802f7208ebc0-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802f7208ebc0-context').style.display = (document.getElementById('cakeErr6802f7208ebc0-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6802f7208ebc0-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr6802f7208ebc0-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 16806,
		&#039;title&#039; =&gt; &#039;Curb on over-the-counter sale of 92 antibiotics soon -Kounteya Sinha&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India&lt;br /&gt;
&lt;br /&gt;
Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in the Drugs and Cosmetics Rules.&lt;br /&gt;
&lt;br /&gt;
Once notified, following clearance from the law ministry, these drugs cannot be sold without prescription.&lt;br /&gt;
&lt;br /&gt;
The drugs will also have to carry a prominent label in red colour on the left corner with the following warning: &amp;quot;It is dangerous to take this prescription except in accordance with medical advice and not to be sold by retail without the prescription of the registered medical practitioner.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Dr Singh said important drugs that Indians are becoming resistant to or can become resistant to are being put under schedule H1.&lt;br /&gt;
&lt;br /&gt;
He added, &amp;quot;These drugs will only be sold against a prescription that the chemist will have to retain. The label of these drugs will have to carry a special warning. I am instructing the state drug controller generals to be ready to conduct surprise check on compliance of retailers once H1 is notified.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
A Union health ministry official said, &amp;quot;The draft rules to amend the Drugs and Cosmetic Rules were earlier published. We will look at the public feedbacks as soon as the monsoon session in Parliament is over. We intend to notify H1 after the law ministry clears it.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Resistance to antibiotics is becoming a serious threat for India because of popular habit to pop pills at will.&lt;br /&gt;
&lt;br /&gt;
Even the World Health Organization (WHO) recently warned that the world is staring at a post-antibiotic era, when common infections will no longer have a cure.&lt;br /&gt;
&lt;br /&gt;
WHO director general Dr Margaret Chan had said, &amp;quot;The world is on the brink of losing these miracle cures.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Even director of Centres for Disease Control Atlanta chief Dr Thomas R Frieden, who was in India, told the TOI that drug resistance due to irrational use of antibiotics will increase in the future.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;It is very important that India came out with a policy to control irrational use of antibiotics. Superbugs like NDM1 and drug resistance are definitely major threats,&amp;quot; Dr Frieden had said.&lt;br /&gt;
&lt;br /&gt;
A recent study by the Centre for Disease Dynamics, Economics and Policy, Washington DC, said there has been a six-fold increase in the number of antibiotics being popped by Indians.&lt;br /&gt;
&lt;br /&gt;
This includes the retail sale of Carbapenems &amp;mdash; a powerful class IV antibiotics, typically used as a &amp;quot;last resort&amp;quot; to treat serious infections caused by multi-drug resistant, gram-negative pathogens.&lt;br /&gt;
&lt;br /&gt;
The CDDEP study said that retail sale of carbapenems increased six times &amp;mdash; from 0.21 units per million in 2005 to 1.23 in 2010 &amp;mdash; raising serious fears of resistance to these drugs.&lt;br /&gt;
&lt;br /&gt;
The Centre said that based on pharmaceutical audit data from IMS Health&#039;s Multinational Integrated Data Analysis System (MIDAS), the size of the carbapenem retail market in India was $27.4 million (Rs 119.4 crore) in 2010.&lt;br /&gt;
&lt;br /&gt;
The drugs to come under H1 includes Moxifloxacin, Meropenem, Imipenem, Ertapenem, Doripenem, Colistin, Linezolid, Cefpirome, Gentamicin, Amikacin, Pencillin, Oxacilin, Zolpidem, Cefalexin, Norfloxacin, Cefaclor, Cefdinir, Tigecycline, Tobramycin, Tramadol and Vancomycin.&lt;br /&gt;
&lt;br /&gt;
CDDEP says the highly competitive domestic pharmaceutical industry in India could play a role in the rapid growth of carbapenem overuse. Based on search of the CIMS, there are over 55 brand names of carbapenem antibiotics retailed on the Indian market.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;&amp;quot;This is a lot, considering carbapenems are a relatively new antibiotic class with only four drugs: meropenem (most popular in India), imipenem/cilastatin, ertapenem and doripenem (the newest and most expensive one). By comparison, there were only six product names in Pakistan and five in the US,&amp;quot; the study said.&lt;br /&gt;
&lt;br /&gt;
According to Chan, when antibiotics were first introduced in the 1940s, they were hailed as wonder drugs. &amp;quot;Widespread infections that killed millions could be cured. Major diseases, like syphilis, gonorrhea, leprosy and tuberculosis lost much of their sting,&amp;quot; she added.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 4 September, 2012, http://timesofindia.indiatimes.com/india/Curb-on-over-the-counter-sale-of-92-antibiotics-soon/articleshow/16241650.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;curb-on-over-the-counter-sale-of-92-antibiotics-soon-kounteya-sinha-16934&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 16934,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 16806,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Curb on over-the-counter sale of 92 antibiotics soon -Kounteya Sinha&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India

Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;br /&gt;&lt;br /&gt;Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in the Drugs and Cosmetics Rules.&lt;br /&gt;&lt;br /&gt;Once notified, following clearance from the law ministry, these drugs cannot be sold without prescription.&lt;br /&gt;&lt;br /&gt;The drugs will also have to carry a prominent label in red colour on the left corner with the following warning: &amp;quot;It is dangerous to take this prescription except in accordance with medical advice and not to be sold by retail without the prescription of the registered medical practitioner.&amp;quot;&lt;br /&gt;&lt;br /&gt;Dr Singh said important drugs that Indians are becoming resistant to or can become resistant to are being put under schedule H1.&lt;br /&gt;&lt;br /&gt;He added, &amp;quot;These drugs will only be sold against a prescription that the chemist will have to retain. The label of these drugs will have to carry a special warning. I am instructing the state drug controller generals to be ready to conduct surprise check on compliance of retailers once H1 is notified.&amp;quot;&lt;br /&gt;&lt;br /&gt;A Union health ministry official said, &amp;quot;The draft rules to amend the Drugs and Cosmetic Rules were earlier published. We will look at the public feedbacks as soon as the monsoon session in Parliament is over. We intend to notify H1 after the law ministry clears it.&amp;quot;&lt;br /&gt;&lt;br /&gt;Resistance to antibiotics is becoming a serious threat for India because of popular habit to pop pills at will.&lt;br /&gt;&lt;br /&gt;Even the World Health Organization (WHO) recently warned that the world is staring at a post-antibiotic era, when common infections will no longer have a cure.&lt;br /&gt;&lt;br /&gt;WHO director general Dr Margaret Chan had said, &amp;quot;The world is on the brink of losing these miracle cures.&amp;quot;&lt;br /&gt;&lt;br /&gt;Even director of Centres for Disease Control Atlanta chief Dr Thomas R Frieden, who was in India, told the TOI that drug resistance due to irrational use of antibiotics will increase in the future.&lt;br /&gt;&lt;br /&gt;&amp;quot;It is very important that India came out with a policy to control irrational use of antibiotics. Superbugs like NDM1 and drug resistance are definitely major threats,&amp;quot; Dr Frieden had said.&lt;br /&gt;&lt;br /&gt;A recent study by the Centre for Disease Dynamics, Economics and Policy, Washington DC, said there has been a six-fold increase in the number of antibiotics being popped by Indians.&lt;br /&gt;&lt;br /&gt;This includes the retail sale of Carbapenems &amp;mdash; a powerful class IV antibiotics, typically used as a &amp;quot;last resort&amp;quot; to treat serious infections caused by multi-drug resistant, gram-negative pathogens.&lt;br /&gt;&lt;br /&gt;The CDDEP study said that retail sale of carbapenems increased six times &amp;mdash; from 0.21 units per million in 2005 to 1.23 in 2010 &amp;mdash; raising serious fears of resistance to these drugs.&lt;br /&gt;&lt;br /&gt;The Centre said that based on pharmaceutical audit data from IMS Health&#039;s Multinational Integrated Data Analysis System (MIDAS), the size of the carbapenem retail market in India was $27.4 million (Rs 119.4 crore) in 2010.&lt;br /&gt;&lt;br /&gt;The drugs to come under H1 includes Moxifloxacin, Meropenem, Imipenem, Ertapenem, Doripenem, Colistin, Linezolid, Cefpirome, Gentamicin, Amikacin, Pencillin, Oxacilin, Zolpidem, Cefalexin, Norfloxacin, Cefaclor, Cefdinir, Tigecycline, Tobramycin, Tramadol and Vancomycin.&lt;br /&gt;&lt;br /&gt;CDDEP says the highly competitive domestic pharmaceutical industry in India could play a role in the rapid growth of carbapenem overuse. Based on search of the CIMS, there are over 55 brand names of carbapenem antibiotics retailed on the Indian market.&lt;br /&gt;&lt;br /&gt;&amp;quot;&amp;quot;This is a lot, considering carbapenems are a relatively new antibiotic class with only four drugs: meropenem (most popular in India), imipenem/cilastatin, ertapenem and doripenem (the newest and most expensive one). By comparison, there were only six product names in Pakistan and five in the US,&amp;quot; the study said.&lt;br /&gt;&lt;br /&gt;According to Chan, when antibiotics were first introduced in the 1940s, they were hailed as wonder drugs. &amp;quot;Widespread infections that killed millions could be cured. Major diseases, like syphilis, gonorrhea, leprosy and tuberculosis lost much of their sting,&amp;quot; she added.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 16806,
	&#039;title&#039; =&gt; &#039;Curb on over-the-counter sale of 92 antibiotics soon -Kounteya Sinha&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India&lt;br /&gt;
&lt;br /&gt;
Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in the Drugs and Cosmetics Rules.&lt;br /&gt;
&lt;br /&gt;
Once notified, following clearance from the law ministry, these drugs cannot be sold without prescription.&lt;br /&gt;
&lt;br /&gt;
The drugs will also have to carry a prominent label in red colour on the left corner with the following warning: &amp;quot;It is dangerous to take this prescription except in accordance with medical advice and not to be sold by retail without the prescription of the registered medical practitioner.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Dr Singh said important drugs that Indians are becoming resistant to or can become resistant to are being put under schedule H1.&lt;br /&gt;
&lt;br /&gt;
He added, &amp;quot;These drugs will only be sold against a prescription that the chemist will have to retain. The label of these drugs will have to carry a special warning. I am instructing the state drug controller generals to be ready to conduct surprise check on compliance of retailers once H1 is notified.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
A Union health ministry official said, &amp;quot;The draft rules to amend the Drugs and Cosmetic Rules were earlier published. We will look at the public feedbacks as soon as the monsoon session in Parliament is over. We intend to notify H1 after the law ministry clears it.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Resistance to antibiotics is becoming a serious threat for India because of popular habit to pop pills at will.&lt;br /&gt;
&lt;br /&gt;
Even the World Health Organization (WHO) recently warned that the world is staring at a post-antibiotic era, when common infections will no longer have a cure.&lt;br /&gt;
&lt;br /&gt;
WHO director general Dr Margaret Chan had said, &amp;quot;The world is on the brink of losing these miracle cures.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Even director of Centres for Disease Control Atlanta chief Dr Thomas R Frieden, who was in India, told the TOI that drug resistance due to irrational use of antibiotics will increase in the future.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;It is very important that India came out with a policy to control irrational use of antibiotics. Superbugs like NDM1 and drug resistance are definitely major threats,&amp;quot; Dr Frieden had said.&lt;br /&gt;
&lt;br /&gt;
A recent study by the Centre for Disease Dynamics, Economics and Policy, Washington DC, said there has been a six-fold increase in the number of antibiotics being popped by Indians.&lt;br /&gt;
&lt;br /&gt;
This includes the retail sale of Carbapenems &amp;mdash; a powerful class IV antibiotics, typically used as a &amp;quot;last resort&amp;quot; to treat serious infections caused by multi-drug resistant, gram-negative pathogens.&lt;br /&gt;
&lt;br /&gt;
The CDDEP study said that retail sale of carbapenems increased six times &amp;mdash; from 0.21 units per million in 2005 to 1.23 in 2010 &amp;mdash; raising serious fears of resistance to these drugs.&lt;br /&gt;
&lt;br /&gt;
The Centre said that based on pharmaceutical audit data from IMS Health&#039;s Multinational Integrated Data Analysis System (MIDAS), the size of the carbapenem retail market in India was $27.4 million (Rs 119.4 crore) in 2010.&lt;br /&gt;
&lt;br /&gt;
The drugs to come under H1 includes Moxifloxacin, Meropenem, Imipenem, Ertapenem, Doripenem, Colistin, Linezolid, Cefpirome, Gentamicin, Amikacin, Pencillin, Oxacilin, Zolpidem, Cefalexin, Norfloxacin, Cefaclor, Cefdinir, Tigecycline, Tobramycin, Tramadol and Vancomycin.&lt;br /&gt;
&lt;br /&gt;
CDDEP says the highly competitive domestic pharmaceutical industry in India could play a role in the rapid growth of carbapenem overuse. Based on search of the CIMS, there are over 55 brand names of carbapenem antibiotics retailed on the Indian market.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;&amp;quot;This is a lot, considering carbapenems are a relatively new antibiotic class with only four drugs: meropenem (most popular in India), imipenem/cilastatin, ertapenem and doripenem (the newest and most expensive one). By comparison, there were only six product names in Pakistan and five in the US,&amp;quot; the study said.&lt;br /&gt;
&lt;br /&gt;
According to Chan, when antibiotics were first introduced in the 1940s, they were hailed as wonder drugs. &amp;quot;Widespread infections that killed millions could be cured. Major diseases, like syphilis, gonorrhea, leprosy and tuberculosis lost much of their sting,&amp;quot; she added.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 4 September, 2012, http://timesofindia.indiatimes.com/india/Curb-on-over-the-counter-sale-of-92-antibiotics-soon/articleshow/16241650.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;curb-on-over-the-counter-sale-of-92-antibiotics-soon-kounteya-sinha-16934&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 16934,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 16806
$metaTitle = &#039;LATEST NEWS UPDATES | Curb on over-the-counter sale of 92 antibiotics soon -Kounteya Sinha&#039;
$metaKeywords = &#039;medicines,Health&#039;
$metaDesc = &#039;
-The Times of India

Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;br /&gt;&lt;br /&gt;Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in the Drugs and Cosmetics Rules.&lt;br /&gt;&lt;br /&gt;Once notified, following clearance from the law ministry, these drugs cannot be sold without prescription.&lt;br /&gt;&lt;br /&gt;The drugs will also have to carry a prominent label in red colour on the left corner with the following warning: &amp;quot;It is dangerous to take this prescription except in accordance with medical advice and not to be sold by retail without the prescription of the registered medical practitioner.&amp;quot;&lt;br /&gt;&lt;br /&gt;Dr Singh said important drugs that Indians are becoming resistant to or can become resistant to are being put under schedule H1.&lt;br /&gt;&lt;br /&gt;He added, &amp;quot;These drugs will only be sold against a prescription that the chemist will have to retain. The label of these drugs will have to carry a special warning. I am instructing the state drug controller generals to be ready to conduct surprise check on compliance of retailers once H1 is notified.&amp;quot;&lt;br /&gt;&lt;br /&gt;A Union health ministry official said, &amp;quot;The draft rules to amend the Drugs and Cosmetic Rules were earlier published. We will look at the public feedbacks as soon as the monsoon session in Parliament is over. We intend to notify H1 after the law ministry clears it.&amp;quot;&lt;br /&gt;&lt;br /&gt;Resistance to antibiotics is becoming a serious threat for India because of popular habit to pop pills at will.&lt;br /&gt;&lt;br /&gt;Even the World Health Organization (WHO) recently warned that the world is staring at a post-antibiotic era, when common infections will no longer have a cure.&lt;br /&gt;&lt;br /&gt;WHO director general Dr Margaret Chan had said, &amp;quot;The world is on the brink of losing these miracle cures.&amp;quot;&lt;br /&gt;&lt;br /&gt;Even director of Centres for Disease Control Atlanta chief Dr Thomas R Frieden, who was in India, told the TOI that drug resistance due to irrational use of antibiotics will increase in the future.&lt;br /&gt;&lt;br /&gt;&amp;quot;It is very important that India came out with a policy to control irrational use of antibiotics. Superbugs like NDM1 and drug resistance are definitely major threats,&amp;quot; Dr Frieden had said.&lt;br /&gt;&lt;br /&gt;A recent study by the Centre for Disease Dynamics, Economics and Policy, Washington DC, said there has been a six-fold increase in the number of antibiotics being popped by Indians.&lt;br /&gt;&lt;br /&gt;This includes the retail sale of Carbapenems &amp;mdash; a powerful class IV antibiotics, typically used as a &amp;quot;last resort&amp;quot; to treat serious infections caused by multi-drug resistant, gram-negative pathogens.&lt;br /&gt;&lt;br /&gt;The CDDEP study said that retail sale of carbapenems increased six times &amp;mdash; from 0.21 units per million in 2005 to 1.23 in 2010 &amp;mdash; raising serious fears of resistance to these drugs.&lt;br /&gt;&lt;br /&gt;The Centre said that based on pharmaceutical audit data from IMS Health&#039;s Multinational Integrated Data Analysis System (MIDAS), the size of the carbapenem retail market in India was $27.4 million (Rs 119.4 crore) in 2010.&lt;br /&gt;&lt;br /&gt;The drugs to come under H1 includes Moxifloxacin, Meropenem, Imipenem, Ertapenem, Doripenem, Colistin, Linezolid, Cefpirome, Gentamicin, Amikacin, Pencillin, Oxacilin, Zolpidem, Cefalexin, Norfloxacin, Cefaclor, Cefdinir, Tigecycline, Tobramycin, Tramadol and Vancomycin.&lt;br /&gt;&lt;br /&gt;CDDEP says the highly competitive domestic pharmaceutical industry in India could play a role in the rapid growth of carbapenem overuse. Based on search of the CIMS, there are over 55 brand names of carbapenem antibiotics retailed on the Indian market.&lt;br /&gt;&lt;br /&gt;&amp;quot;&amp;quot;This is a lot, considering carbapenems are a relatively new antibiotic class with only four drugs: meropenem (most popular in India), imipenem/cilastatin, ertapenem and doripenem (the newest and most expensive one). By comparison, there were only six product names in Pakistan and five in the US,&amp;quot; the study said.&lt;br /&gt;&lt;br /&gt;According to Chan, when antibiotics were first introduced in the 1940s, they were hailed as wonder drugs. &amp;quot;Widespread infections that killed millions could be cured. Major diseases, like syphilis, gonorrhea, leprosy and tuberculosis lost much of their sting,&amp;quot; she added.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/curb-on-over-the-counter-sale-of-92-antibiotics-soon-kounteya-sinha-16934.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Curb on over-the-counter sale of 92 antibiotics soon -Kounteya Sinha | Im4change.org</title>
    <meta name="description" content="
-The Times of India

Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Curb on over-the-counter sale of 92 antibiotics soon -Kounteya Sinha</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India<br /><br />Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in the Drugs and Cosmetics Rules.<br /><br />Once notified, following clearance from the law ministry, these drugs cannot be sold without prescription.<br /><br />The drugs will also have to carry a prominent label in red colour on the left corner with the following warning: &quot;It is dangerous to take this prescription except in accordance with medical advice and not to be sold by retail without the prescription of the registered medical practitioner.&quot;<br /><br />Dr Singh said important drugs that Indians are becoming resistant to or can become resistant to are being put under schedule H1.<br /><br />He added, &quot;These drugs will only be sold against a prescription that the chemist will have to retain. The label of these drugs will have to carry a special warning. I am instructing the state drug controller generals to be ready to conduct surprise check on compliance of retailers once H1 is notified.&quot;<br /><br />A Union health ministry official said, &quot;The draft rules to amend the Drugs and Cosmetic Rules were earlier published. We will look at the public feedbacks as soon as the monsoon session in Parliament is over. We intend to notify H1 after the law ministry clears it.&quot;<br /><br />Resistance to antibiotics is becoming a serious threat for India because of popular habit to pop pills at will.<br /><br />Even the World Health Organization (WHO) recently warned that the world is staring at a post-antibiotic era, when common infections will no longer have a cure.<br /><br />WHO director general Dr Margaret Chan had said, &quot;The world is on the brink of losing these miracle cures.&quot;<br /><br />Even director of Centres for Disease Control Atlanta chief Dr Thomas R Frieden, who was in India, told the TOI that drug resistance due to irrational use of antibiotics will increase in the future.<br /><br />&quot;It is very important that India came out with a policy to control irrational use of antibiotics. Superbugs like NDM1 and drug resistance are definitely major threats,&quot; Dr Frieden had said.<br /><br />A recent study by the Centre for Disease Dynamics, Economics and Policy, Washington DC, said there has been a six-fold increase in the number of antibiotics being popped by Indians.<br /><br />This includes the retail sale of Carbapenems &mdash; a powerful class IV antibiotics, typically used as a &quot;last resort&quot; to treat serious infections caused by multi-drug resistant, gram-negative pathogens.<br /><br />The CDDEP study said that retail sale of carbapenems increased six times &mdash; from 0.21 units per million in 2005 to 1.23 in 2010 &mdash; raising serious fears of resistance to these drugs.<br /><br />The Centre said that based on pharmaceutical audit data from IMS Health's Multinational Integrated Data Analysis System (MIDAS), the size of the carbapenem retail market in India was $27.4 million (Rs 119.4 crore) in 2010.<br /><br />The drugs to come under H1 includes Moxifloxacin, Meropenem, Imipenem, Ertapenem, Doripenem, Colistin, Linezolid, Cefpirome, Gentamicin, Amikacin, Pencillin, Oxacilin, Zolpidem, Cefalexin, Norfloxacin, Cefaclor, Cefdinir, Tigecycline, Tobramycin, Tramadol and Vancomycin.<br /><br />CDDEP says the highly competitive domestic pharmaceutical industry in India could play a role in the rapid growth of carbapenem overuse. Based on search of the CIMS, there are over 55 brand names of carbapenem antibiotics retailed on the Indian market.<br /><br />&quot;&quot;This is a lot, considering carbapenems are a relatively new antibiotic class with only four drugs: meropenem (most popular in India), imipenem/cilastatin, ertapenem and doripenem (the newest and most expensive one). By comparison, there were only six product names in Pakistan and five in the US,&quot; the study said.<br /><br />According to Chan, when antibiotics were first introduced in the 1940s, they were hailed as wonder drugs. &quot;Widespread infections that killed millions could be cured. Major diseases, like syphilis, gonorrhea, leprosy and tuberculosis lost much of their sting,&quot; she added.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802f7208ebc0-trace').style.display = (document.getElementById('cakeErr6802f7208ebc0-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6802f7208ebc0-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802f7208ebc0-code').style.display = (document.getElementById('cakeErr6802f7208ebc0-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802f7208ebc0-context').style.display = (document.getElementById('cakeErr6802f7208ebc0-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6802f7208ebc0-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr6802f7208ebc0-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 16806,
		&#039;title&#039; =&gt; &#039;Curb on over-the-counter sale of 92 antibiotics soon -Kounteya Sinha&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India&lt;br /&gt;
&lt;br /&gt;
Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in the Drugs and Cosmetics Rules.&lt;br /&gt;
&lt;br /&gt;
Once notified, following clearance from the law ministry, these drugs cannot be sold without prescription.&lt;br /&gt;
&lt;br /&gt;
The drugs will also have to carry a prominent label in red colour on the left corner with the following warning: &amp;quot;It is dangerous to take this prescription except in accordance with medical advice and not to be sold by retail without the prescription of the registered medical practitioner.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Dr Singh said important drugs that Indians are becoming resistant to or can become resistant to are being put under schedule H1.&lt;br /&gt;
&lt;br /&gt;
He added, &amp;quot;These drugs will only be sold against a prescription that the chemist will have to retain. The label of these drugs will have to carry a special warning. I am instructing the state drug controller generals to be ready to conduct surprise check on compliance of retailers once H1 is notified.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
A Union health ministry official said, &amp;quot;The draft rules to amend the Drugs and Cosmetic Rules were earlier published. We will look at the public feedbacks as soon as the monsoon session in Parliament is over. We intend to notify H1 after the law ministry clears it.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Resistance to antibiotics is becoming a serious threat for India because of popular habit to pop pills at will.&lt;br /&gt;
&lt;br /&gt;
Even the World Health Organization (WHO) recently warned that the world is staring at a post-antibiotic era, when common infections will no longer have a cure.&lt;br /&gt;
&lt;br /&gt;
WHO director general Dr Margaret Chan had said, &amp;quot;The world is on the brink of losing these miracle cures.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Even director of Centres for Disease Control Atlanta chief Dr Thomas R Frieden, who was in India, told the TOI that drug resistance due to irrational use of antibiotics will increase in the future.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;It is very important that India came out with a policy to control irrational use of antibiotics. Superbugs like NDM1 and drug resistance are definitely major threats,&amp;quot; Dr Frieden had said.&lt;br /&gt;
&lt;br /&gt;
A recent study by the Centre for Disease Dynamics, Economics and Policy, Washington DC, said there has been a six-fold increase in the number of antibiotics being popped by Indians.&lt;br /&gt;
&lt;br /&gt;
This includes the retail sale of Carbapenems &amp;mdash; a powerful class IV antibiotics, typically used as a &amp;quot;last resort&amp;quot; to treat serious infections caused by multi-drug resistant, gram-negative pathogens.&lt;br /&gt;
&lt;br /&gt;
The CDDEP study said that retail sale of carbapenems increased six times &amp;mdash; from 0.21 units per million in 2005 to 1.23 in 2010 &amp;mdash; raising serious fears of resistance to these drugs.&lt;br /&gt;
&lt;br /&gt;
The Centre said that based on pharmaceutical audit data from IMS Health&#039;s Multinational Integrated Data Analysis System (MIDAS), the size of the carbapenem retail market in India was $27.4 million (Rs 119.4 crore) in 2010.&lt;br /&gt;
&lt;br /&gt;
The drugs to come under H1 includes Moxifloxacin, Meropenem, Imipenem, Ertapenem, Doripenem, Colistin, Linezolid, Cefpirome, Gentamicin, Amikacin, Pencillin, Oxacilin, Zolpidem, Cefalexin, Norfloxacin, Cefaclor, Cefdinir, Tigecycline, Tobramycin, Tramadol and Vancomycin.&lt;br /&gt;
&lt;br /&gt;
CDDEP says the highly competitive domestic pharmaceutical industry in India could play a role in the rapid growth of carbapenem overuse. Based on search of the CIMS, there are over 55 brand names of carbapenem antibiotics retailed on the Indian market.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;&amp;quot;This is a lot, considering carbapenems are a relatively new antibiotic class with only four drugs: meropenem (most popular in India), imipenem/cilastatin, ertapenem and doripenem (the newest and most expensive one). By comparison, there were only six product names in Pakistan and five in the US,&amp;quot; the study said.&lt;br /&gt;
&lt;br /&gt;
According to Chan, when antibiotics were first introduced in the 1940s, they were hailed as wonder drugs. &amp;quot;Widespread infections that killed millions could be cured. Major diseases, like syphilis, gonorrhea, leprosy and tuberculosis lost much of their sting,&amp;quot; she added.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 4 September, 2012, http://timesofindia.indiatimes.com/india/Curb-on-over-the-counter-sale-of-92-antibiotics-soon/articleshow/16241650.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;curb-on-over-the-counter-sale-of-92-antibiotics-soon-kounteya-sinha-16934&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 16934,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 16806,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Curb on over-the-counter sale of 92 antibiotics soon -Kounteya Sinha&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India

Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;br /&gt;&lt;br /&gt;Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in the Drugs and Cosmetics Rules.&lt;br /&gt;&lt;br /&gt;Once notified, following clearance from the law ministry, these drugs cannot be sold without prescription.&lt;br /&gt;&lt;br /&gt;The drugs will also have to carry a prominent label in red colour on the left corner with the following warning: &amp;quot;It is dangerous to take this prescription except in accordance with medical advice and not to be sold by retail without the prescription of the registered medical practitioner.&amp;quot;&lt;br /&gt;&lt;br /&gt;Dr Singh said important drugs that Indians are becoming resistant to or can become resistant to are being put under schedule H1.&lt;br /&gt;&lt;br /&gt;He added, &amp;quot;These drugs will only be sold against a prescription that the chemist will have to retain. The label of these drugs will have to carry a special warning. I am instructing the state drug controller generals to be ready to conduct surprise check on compliance of retailers once H1 is notified.&amp;quot;&lt;br /&gt;&lt;br /&gt;A Union health ministry official said, &amp;quot;The draft rules to amend the Drugs and Cosmetic Rules were earlier published. We will look at the public feedbacks as soon as the monsoon session in Parliament is over. We intend to notify H1 after the law ministry clears it.&amp;quot;&lt;br /&gt;&lt;br /&gt;Resistance to antibiotics is becoming a serious threat for India because of popular habit to pop pills at will.&lt;br /&gt;&lt;br /&gt;Even the World Health Organization (WHO) recently warned that the world is staring at a post-antibiotic era, when common infections will no longer have a cure.&lt;br /&gt;&lt;br /&gt;WHO director general Dr Margaret Chan had said, &amp;quot;The world is on the brink of losing these miracle cures.&amp;quot;&lt;br /&gt;&lt;br /&gt;Even director of Centres for Disease Control Atlanta chief Dr Thomas R Frieden, who was in India, told the TOI that drug resistance due to irrational use of antibiotics will increase in the future.&lt;br /&gt;&lt;br /&gt;&amp;quot;It is very important that India came out with a policy to control irrational use of antibiotics. Superbugs like NDM1 and drug resistance are definitely major threats,&amp;quot; Dr Frieden had said.&lt;br /&gt;&lt;br /&gt;A recent study by the Centre for Disease Dynamics, Economics and Policy, Washington DC, said there has been a six-fold increase in the number of antibiotics being popped by Indians.&lt;br /&gt;&lt;br /&gt;This includes the retail sale of Carbapenems &amp;mdash; a powerful class IV antibiotics, typically used as a &amp;quot;last resort&amp;quot; to treat serious infections caused by multi-drug resistant, gram-negative pathogens.&lt;br /&gt;&lt;br /&gt;The CDDEP study said that retail sale of carbapenems increased six times &amp;mdash; from 0.21 units per million in 2005 to 1.23 in 2010 &amp;mdash; raising serious fears of resistance to these drugs.&lt;br /&gt;&lt;br /&gt;The Centre said that based on pharmaceutical audit data from IMS Health&#039;s Multinational Integrated Data Analysis System (MIDAS), the size of the carbapenem retail market in India was $27.4 million (Rs 119.4 crore) in 2010.&lt;br /&gt;&lt;br /&gt;The drugs to come under H1 includes Moxifloxacin, Meropenem, Imipenem, Ertapenem, Doripenem, Colistin, Linezolid, Cefpirome, Gentamicin, Amikacin, Pencillin, Oxacilin, Zolpidem, Cefalexin, Norfloxacin, Cefaclor, Cefdinir, Tigecycline, Tobramycin, Tramadol and Vancomycin.&lt;br /&gt;&lt;br /&gt;CDDEP says the highly competitive domestic pharmaceutical industry in India could play a role in the rapid growth of carbapenem overuse. Based on search of the CIMS, there are over 55 brand names of carbapenem antibiotics retailed on the Indian market.&lt;br /&gt;&lt;br /&gt;&amp;quot;&amp;quot;This is a lot, considering carbapenems are a relatively new antibiotic class with only four drugs: meropenem (most popular in India), imipenem/cilastatin, ertapenem and doripenem (the newest and most expensive one). By comparison, there were only six product names in Pakistan and five in the US,&amp;quot; the study said.&lt;br /&gt;&lt;br /&gt;According to Chan, when antibiotics were first introduced in the 1940s, they were hailed as wonder drugs. &amp;quot;Widespread infections that killed millions could be cured. Major diseases, like syphilis, gonorrhea, leprosy and tuberculosis lost much of their sting,&amp;quot; she added.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 16806,
	&#039;title&#039; =&gt; &#039;Curb on over-the-counter sale of 92 antibiotics soon -Kounteya Sinha&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India&lt;br /&gt;
&lt;br /&gt;
Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in the Drugs and Cosmetics Rules.&lt;br /&gt;
&lt;br /&gt;
Once notified, following clearance from the law ministry, these drugs cannot be sold without prescription.&lt;br /&gt;
&lt;br /&gt;
The drugs will also have to carry a prominent label in red colour on the left corner with the following warning: &amp;quot;It is dangerous to take this prescription except in accordance with medical advice and not to be sold by retail without the prescription of the registered medical practitioner.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Dr Singh said important drugs that Indians are becoming resistant to or can become resistant to are being put under schedule H1.&lt;br /&gt;
&lt;br /&gt;
He added, &amp;quot;These drugs will only be sold against a prescription that the chemist will have to retain. The label of these drugs will have to carry a special warning. I am instructing the state drug controller generals to be ready to conduct surprise check on compliance of retailers once H1 is notified.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
A Union health ministry official said, &amp;quot;The draft rules to amend the Drugs and Cosmetic Rules were earlier published. We will look at the public feedbacks as soon as the monsoon session in Parliament is over. We intend to notify H1 after the law ministry clears it.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Resistance to antibiotics is becoming a serious threat for India because of popular habit to pop pills at will.&lt;br /&gt;
&lt;br /&gt;
Even the World Health Organization (WHO) recently warned that the world is staring at a post-antibiotic era, when common infections will no longer have a cure.&lt;br /&gt;
&lt;br /&gt;
WHO director general Dr Margaret Chan had said, &amp;quot;The world is on the brink of losing these miracle cures.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Even director of Centres for Disease Control Atlanta chief Dr Thomas R Frieden, who was in India, told the TOI that drug resistance due to irrational use of antibiotics will increase in the future.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;It is very important that India came out with a policy to control irrational use of antibiotics. Superbugs like NDM1 and drug resistance are definitely major threats,&amp;quot; Dr Frieden had said.&lt;br /&gt;
&lt;br /&gt;
A recent study by the Centre for Disease Dynamics, Economics and Policy, Washington DC, said there has been a six-fold increase in the number of antibiotics being popped by Indians.&lt;br /&gt;
&lt;br /&gt;
This includes the retail sale of Carbapenems &amp;mdash; a powerful class IV antibiotics, typically used as a &amp;quot;last resort&amp;quot; to treat serious infections caused by multi-drug resistant, gram-negative pathogens.&lt;br /&gt;
&lt;br /&gt;
The CDDEP study said that retail sale of carbapenems increased six times &amp;mdash; from 0.21 units per million in 2005 to 1.23 in 2010 &amp;mdash; raising serious fears of resistance to these drugs.&lt;br /&gt;
&lt;br /&gt;
The Centre said that based on pharmaceutical audit data from IMS Health&#039;s Multinational Integrated Data Analysis System (MIDAS), the size of the carbapenem retail market in India was $27.4 million (Rs 119.4 crore) in 2010.&lt;br /&gt;
&lt;br /&gt;
The drugs to come under H1 includes Moxifloxacin, Meropenem, Imipenem, Ertapenem, Doripenem, Colistin, Linezolid, Cefpirome, Gentamicin, Amikacin, Pencillin, Oxacilin, Zolpidem, Cefalexin, Norfloxacin, Cefaclor, Cefdinir, Tigecycline, Tobramycin, Tramadol and Vancomycin.&lt;br /&gt;
&lt;br /&gt;
CDDEP says the highly competitive domestic pharmaceutical industry in India could play a role in the rapid growth of carbapenem overuse. Based on search of the CIMS, there are over 55 brand names of carbapenem antibiotics retailed on the Indian market.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;&amp;quot;This is a lot, considering carbapenems are a relatively new antibiotic class with only four drugs: meropenem (most popular in India), imipenem/cilastatin, ertapenem and doripenem (the newest and most expensive one). By comparison, there were only six product names in Pakistan and five in the US,&amp;quot; the study said.&lt;br /&gt;
&lt;br /&gt;
According to Chan, when antibiotics were first introduced in the 1940s, they were hailed as wonder drugs. &amp;quot;Widespread infections that killed millions could be cured. Major diseases, like syphilis, gonorrhea, leprosy and tuberculosis lost much of their sting,&amp;quot; she added.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 4 September, 2012, http://timesofindia.indiatimes.com/india/Curb-on-over-the-counter-sale-of-92-antibiotics-soon/articleshow/16241650.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;curb-on-over-the-counter-sale-of-92-antibiotics-soon-kounteya-sinha-16934&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 16934,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 16806
$metaTitle = &#039;LATEST NEWS UPDATES | Curb on over-the-counter sale of 92 antibiotics soon -Kounteya Sinha&#039;
$metaKeywords = &#039;medicines,Health&#039;
$metaDesc = &#039;
-The Times of India

Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;br /&gt;&lt;br /&gt;Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in the Drugs and Cosmetics Rules.&lt;br /&gt;&lt;br /&gt;Once notified, following clearance from the law ministry, these drugs cannot be sold without prescription.&lt;br /&gt;&lt;br /&gt;The drugs will also have to carry a prominent label in red colour on the left corner with the following warning: &amp;quot;It is dangerous to take this prescription except in accordance with medical advice and not to be sold by retail without the prescription of the registered medical practitioner.&amp;quot;&lt;br /&gt;&lt;br /&gt;Dr Singh said important drugs that Indians are becoming resistant to or can become resistant to are being put under schedule H1.&lt;br /&gt;&lt;br /&gt;He added, &amp;quot;These drugs will only be sold against a prescription that the chemist will have to retain. The label of these drugs will have to carry a special warning. I am instructing the state drug controller generals to be ready to conduct surprise check on compliance of retailers once H1 is notified.&amp;quot;&lt;br /&gt;&lt;br /&gt;A Union health ministry official said, &amp;quot;The draft rules to amend the Drugs and Cosmetic Rules were earlier published. We will look at the public feedbacks as soon as the monsoon session in Parliament is over. We intend to notify H1 after the law ministry clears it.&amp;quot;&lt;br /&gt;&lt;br /&gt;Resistance to antibiotics is becoming a serious threat for India because of popular habit to pop pills at will.&lt;br /&gt;&lt;br /&gt;Even the World Health Organization (WHO) recently warned that the world is staring at a post-antibiotic era, when common infections will no longer have a cure.&lt;br /&gt;&lt;br /&gt;WHO director general Dr Margaret Chan had said, &amp;quot;The world is on the brink of losing these miracle cures.&amp;quot;&lt;br /&gt;&lt;br /&gt;Even director of Centres for Disease Control Atlanta chief Dr Thomas R Frieden, who was in India, told the TOI that drug resistance due to irrational use of antibiotics will increase in the future.&lt;br /&gt;&lt;br /&gt;&amp;quot;It is very important that India came out with a policy to control irrational use of antibiotics. Superbugs like NDM1 and drug resistance are definitely major threats,&amp;quot; Dr Frieden had said.&lt;br /&gt;&lt;br /&gt;A recent study by the Centre for Disease Dynamics, Economics and Policy, Washington DC, said there has been a six-fold increase in the number of antibiotics being popped by Indians.&lt;br /&gt;&lt;br /&gt;This includes the retail sale of Carbapenems &amp;mdash; a powerful class IV antibiotics, typically used as a &amp;quot;last resort&amp;quot; to treat serious infections caused by multi-drug resistant, gram-negative pathogens.&lt;br /&gt;&lt;br /&gt;The CDDEP study said that retail sale of carbapenems increased six times &amp;mdash; from 0.21 units per million in 2005 to 1.23 in 2010 &amp;mdash; raising serious fears of resistance to these drugs.&lt;br /&gt;&lt;br /&gt;The Centre said that based on pharmaceutical audit data from IMS Health&#039;s Multinational Integrated Data Analysis System (MIDAS), the size of the carbapenem retail market in India was $27.4 million (Rs 119.4 crore) in 2010.&lt;br /&gt;&lt;br /&gt;The drugs to come under H1 includes Moxifloxacin, Meropenem, Imipenem, Ertapenem, Doripenem, Colistin, Linezolid, Cefpirome, Gentamicin, Amikacin, Pencillin, Oxacilin, Zolpidem, Cefalexin, Norfloxacin, Cefaclor, Cefdinir, Tigecycline, Tobramycin, Tramadol and Vancomycin.&lt;br /&gt;&lt;br /&gt;CDDEP says the highly competitive domestic pharmaceutical industry in India could play a role in the rapid growth of carbapenem overuse. Based on search of the CIMS, there are over 55 brand names of carbapenem antibiotics retailed on the Indian market.&lt;br /&gt;&lt;br /&gt;&amp;quot;&amp;quot;This is a lot, considering carbapenems are a relatively new antibiotic class with only four drugs: meropenem (most popular in India), imipenem/cilastatin, ertapenem and doripenem (the newest and most expensive one). By comparison, there were only six product names in Pakistan and five in the US,&amp;quot; the study said.&lt;br /&gt;&lt;br /&gt;According to Chan, when antibiotics were first introduced in the 1940s, they were hailed as wonder drugs. &amp;quot;Widespread infections that killed millions could be cured. Major diseases, like syphilis, gonorrhea, leprosy and tuberculosis lost much of their sting,&amp;quot; she added.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/curb-on-over-the-counter-sale-of-92-antibiotics-soon-kounteya-sinha-16934.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Curb on over-the-counter sale of 92 antibiotics soon -Kounteya Sinha | Im4change.org</title>
    <meta name="description" content="
-The Times of India

Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Curb on over-the-counter sale of 92 antibiotics soon -Kounteya Sinha</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India<br /><br />Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in the Drugs and Cosmetics Rules.<br /><br />Once notified, following clearance from the law ministry, these drugs cannot be sold without prescription.<br /><br />The drugs will also have to carry a prominent label in red colour on the left corner with the following warning: &quot;It is dangerous to take this prescription except in accordance with medical advice and not to be sold by retail without the prescription of the registered medical practitioner.&quot;<br /><br />Dr Singh said important drugs that Indians are becoming resistant to or can become resistant to are being put under schedule H1.<br /><br />He added, &quot;These drugs will only be sold against a prescription that the chemist will have to retain. The label of these drugs will have to carry a special warning. I am instructing the state drug controller generals to be ready to conduct surprise check on compliance of retailers once H1 is notified.&quot;<br /><br />A Union health ministry official said, &quot;The draft rules to amend the Drugs and Cosmetic Rules were earlier published. We will look at the public feedbacks as soon as the monsoon session in Parliament is over. We intend to notify H1 after the law ministry clears it.&quot;<br /><br />Resistance to antibiotics is becoming a serious threat for India because of popular habit to pop pills at will.<br /><br />Even the World Health Organization (WHO) recently warned that the world is staring at a post-antibiotic era, when common infections will no longer have a cure.<br /><br />WHO director general Dr Margaret Chan had said, &quot;The world is on the brink of losing these miracle cures.&quot;<br /><br />Even director of Centres for Disease Control Atlanta chief Dr Thomas R Frieden, who was in India, told the TOI that drug resistance due to irrational use of antibiotics will increase in the future.<br /><br />&quot;It is very important that India came out with a policy to control irrational use of antibiotics. Superbugs like NDM1 and drug resistance are definitely major threats,&quot; Dr Frieden had said.<br /><br />A recent study by the Centre for Disease Dynamics, Economics and Policy, Washington DC, said there has been a six-fold increase in the number of antibiotics being popped by Indians.<br /><br />This includes the retail sale of Carbapenems &mdash; a powerful class IV antibiotics, typically used as a &quot;last resort&quot; to treat serious infections caused by multi-drug resistant, gram-negative pathogens.<br /><br />The CDDEP study said that retail sale of carbapenems increased six times &mdash; from 0.21 units per million in 2005 to 1.23 in 2010 &mdash; raising serious fears of resistance to these drugs.<br /><br />The Centre said that based on pharmaceutical audit data from IMS Health's Multinational Integrated Data Analysis System (MIDAS), the size of the carbapenem retail market in India was $27.4 million (Rs 119.4 crore) in 2010.<br /><br />The drugs to come under H1 includes Moxifloxacin, Meropenem, Imipenem, Ertapenem, Doripenem, Colistin, Linezolid, Cefpirome, Gentamicin, Amikacin, Pencillin, Oxacilin, Zolpidem, Cefalexin, Norfloxacin, Cefaclor, Cefdinir, Tigecycline, Tobramycin, Tramadol and Vancomycin.<br /><br />CDDEP says the highly competitive domestic pharmaceutical industry in India could play a role in the rapid growth of carbapenem overuse. Based on search of the CIMS, there are over 55 brand names of carbapenem antibiotics retailed on the Indian market.<br /><br />&quot;&quot;This is a lot, considering carbapenems are a relatively new antibiotic class with only four drugs: meropenem (most popular in India), imipenem/cilastatin, ertapenem and doripenem (the newest and most expensive one). By comparison, there were only six product names in Pakistan and five in the US,&quot; the study said.<br /><br />According to Chan, when antibiotics were first introduced in the 1940s, they were hailed as wonder drugs. &quot;Widespread infections that killed millions could be cured. Major diseases, like syphilis, gonorrhea, leprosy and tuberculosis lost much of their sting,&quot; she added.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802f7208ebc0-trace').style.display = (document.getElementById('cakeErr6802f7208ebc0-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6802f7208ebc0-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802f7208ebc0-code').style.display = (document.getElementById('cakeErr6802f7208ebc0-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802f7208ebc0-context').style.display = (document.getElementById('cakeErr6802f7208ebc0-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6802f7208ebc0-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr6802f7208ebc0-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 16806,
		&#039;title&#039; =&gt; &#039;Curb on over-the-counter sale of 92 antibiotics soon -Kounteya Sinha&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India&lt;br /&gt;
&lt;br /&gt;
Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in the Drugs and Cosmetics Rules.&lt;br /&gt;
&lt;br /&gt;
Once notified, following clearance from the law ministry, these drugs cannot be sold without prescription.&lt;br /&gt;
&lt;br /&gt;
The drugs will also have to carry a prominent label in red colour on the left corner with the following warning: &amp;quot;It is dangerous to take this prescription except in accordance with medical advice and not to be sold by retail without the prescription of the registered medical practitioner.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Dr Singh said important drugs that Indians are becoming resistant to or can become resistant to are being put under schedule H1.&lt;br /&gt;
&lt;br /&gt;
He added, &amp;quot;These drugs will only be sold against a prescription that the chemist will have to retain. The label of these drugs will have to carry a special warning. I am instructing the state drug controller generals to be ready to conduct surprise check on compliance of retailers once H1 is notified.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
A Union health ministry official said, &amp;quot;The draft rules to amend the Drugs and Cosmetic Rules were earlier published. We will look at the public feedbacks as soon as the monsoon session in Parliament is over. We intend to notify H1 after the law ministry clears it.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Resistance to antibiotics is becoming a serious threat for India because of popular habit to pop pills at will.&lt;br /&gt;
&lt;br /&gt;
Even the World Health Organization (WHO) recently warned that the world is staring at a post-antibiotic era, when common infections will no longer have a cure.&lt;br /&gt;
&lt;br /&gt;
WHO director general Dr Margaret Chan had said, &amp;quot;The world is on the brink of losing these miracle cures.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Even director of Centres for Disease Control Atlanta chief Dr Thomas R Frieden, who was in India, told the TOI that drug resistance due to irrational use of antibiotics will increase in the future.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;It is very important that India came out with a policy to control irrational use of antibiotics. Superbugs like NDM1 and drug resistance are definitely major threats,&amp;quot; Dr Frieden had said.&lt;br /&gt;
&lt;br /&gt;
A recent study by the Centre for Disease Dynamics, Economics and Policy, Washington DC, said there has been a six-fold increase in the number of antibiotics being popped by Indians.&lt;br /&gt;
&lt;br /&gt;
This includes the retail sale of Carbapenems &amp;mdash; a powerful class IV antibiotics, typically used as a &amp;quot;last resort&amp;quot; to treat serious infections caused by multi-drug resistant, gram-negative pathogens.&lt;br /&gt;
&lt;br /&gt;
The CDDEP study said that retail sale of carbapenems increased six times &amp;mdash; from 0.21 units per million in 2005 to 1.23 in 2010 &amp;mdash; raising serious fears of resistance to these drugs.&lt;br /&gt;
&lt;br /&gt;
The Centre said that based on pharmaceutical audit data from IMS Health&#039;s Multinational Integrated Data Analysis System (MIDAS), the size of the carbapenem retail market in India was $27.4 million (Rs 119.4 crore) in 2010.&lt;br /&gt;
&lt;br /&gt;
The drugs to come under H1 includes Moxifloxacin, Meropenem, Imipenem, Ertapenem, Doripenem, Colistin, Linezolid, Cefpirome, Gentamicin, Amikacin, Pencillin, Oxacilin, Zolpidem, Cefalexin, Norfloxacin, Cefaclor, Cefdinir, Tigecycline, Tobramycin, Tramadol and Vancomycin.&lt;br /&gt;
&lt;br /&gt;
CDDEP says the highly competitive domestic pharmaceutical industry in India could play a role in the rapid growth of carbapenem overuse. Based on search of the CIMS, there are over 55 brand names of carbapenem antibiotics retailed on the Indian market.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;&amp;quot;This is a lot, considering carbapenems are a relatively new antibiotic class with only four drugs: meropenem (most popular in India), imipenem/cilastatin, ertapenem and doripenem (the newest and most expensive one). By comparison, there were only six product names in Pakistan and five in the US,&amp;quot; the study said.&lt;br /&gt;
&lt;br /&gt;
According to Chan, when antibiotics were first introduced in the 1940s, they were hailed as wonder drugs. &amp;quot;Widespread infections that killed millions could be cured. Major diseases, like syphilis, gonorrhea, leprosy and tuberculosis lost much of their sting,&amp;quot; she added.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 4 September, 2012, http://timesofindia.indiatimes.com/india/Curb-on-over-the-counter-sale-of-92-antibiotics-soon/articleshow/16241650.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;curb-on-over-the-counter-sale-of-92-antibiotics-soon-kounteya-sinha-16934&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 16934,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 16806,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Curb on over-the-counter sale of 92 antibiotics soon -Kounteya Sinha&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India

Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;br /&gt;&lt;br /&gt;Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in the Drugs and Cosmetics Rules.&lt;br /&gt;&lt;br /&gt;Once notified, following clearance from the law ministry, these drugs cannot be sold without prescription.&lt;br /&gt;&lt;br /&gt;The drugs will also have to carry a prominent label in red colour on the left corner with the following warning: &amp;quot;It is dangerous to take this prescription except in accordance with medical advice and not to be sold by retail without the prescription of the registered medical practitioner.&amp;quot;&lt;br /&gt;&lt;br /&gt;Dr Singh said important drugs that Indians are becoming resistant to or can become resistant to are being put under schedule H1.&lt;br /&gt;&lt;br /&gt;He added, &amp;quot;These drugs will only be sold against a prescription that the chemist will have to retain. The label of these drugs will have to carry a special warning. I am instructing the state drug controller generals to be ready to conduct surprise check on compliance of retailers once H1 is notified.&amp;quot;&lt;br /&gt;&lt;br /&gt;A Union health ministry official said, &amp;quot;The draft rules to amend the Drugs and Cosmetic Rules were earlier published. We will look at the public feedbacks as soon as the monsoon session in Parliament is over. We intend to notify H1 after the law ministry clears it.&amp;quot;&lt;br /&gt;&lt;br /&gt;Resistance to antibiotics is becoming a serious threat for India because of popular habit to pop pills at will.&lt;br /&gt;&lt;br /&gt;Even the World Health Organization (WHO) recently warned that the world is staring at a post-antibiotic era, when common infections will no longer have a cure.&lt;br /&gt;&lt;br /&gt;WHO director general Dr Margaret Chan had said, &amp;quot;The world is on the brink of losing these miracle cures.&amp;quot;&lt;br /&gt;&lt;br /&gt;Even director of Centres for Disease Control Atlanta chief Dr Thomas R Frieden, who was in India, told the TOI that drug resistance due to irrational use of antibiotics will increase in the future.&lt;br /&gt;&lt;br /&gt;&amp;quot;It is very important that India came out with a policy to control irrational use of antibiotics. Superbugs like NDM1 and drug resistance are definitely major threats,&amp;quot; Dr Frieden had said.&lt;br /&gt;&lt;br /&gt;A recent study by the Centre for Disease Dynamics, Economics and Policy, Washington DC, said there has been a six-fold increase in the number of antibiotics being popped by Indians.&lt;br /&gt;&lt;br /&gt;This includes the retail sale of Carbapenems &amp;mdash; a powerful class IV antibiotics, typically used as a &amp;quot;last resort&amp;quot; to treat serious infections caused by multi-drug resistant, gram-negative pathogens.&lt;br /&gt;&lt;br /&gt;The CDDEP study said that retail sale of carbapenems increased six times &amp;mdash; from 0.21 units per million in 2005 to 1.23 in 2010 &amp;mdash; raising serious fears of resistance to these drugs.&lt;br /&gt;&lt;br /&gt;The Centre said that based on pharmaceutical audit data from IMS Health&#039;s Multinational Integrated Data Analysis System (MIDAS), the size of the carbapenem retail market in India was $27.4 million (Rs 119.4 crore) in 2010.&lt;br /&gt;&lt;br /&gt;The drugs to come under H1 includes Moxifloxacin, Meropenem, Imipenem, Ertapenem, Doripenem, Colistin, Linezolid, Cefpirome, Gentamicin, Amikacin, Pencillin, Oxacilin, Zolpidem, Cefalexin, Norfloxacin, Cefaclor, Cefdinir, Tigecycline, Tobramycin, Tramadol and Vancomycin.&lt;br /&gt;&lt;br /&gt;CDDEP says the highly competitive domestic pharmaceutical industry in India could play a role in the rapid growth of carbapenem overuse. Based on search of the CIMS, there are over 55 brand names of carbapenem antibiotics retailed on the Indian market.&lt;br /&gt;&lt;br /&gt;&amp;quot;&amp;quot;This is a lot, considering carbapenems are a relatively new antibiotic class with only four drugs: meropenem (most popular in India), imipenem/cilastatin, ertapenem and doripenem (the newest and most expensive one). By comparison, there were only six product names in Pakistan and five in the US,&amp;quot; the study said.&lt;br /&gt;&lt;br /&gt;According to Chan, when antibiotics were first introduced in the 1940s, they were hailed as wonder drugs. &amp;quot;Widespread infections that killed millions could be cured. Major diseases, like syphilis, gonorrhea, leprosy and tuberculosis lost much of their sting,&amp;quot; she added.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 16806,
	&#039;title&#039; =&gt; &#039;Curb on over-the-counter sale of 92 antibiotics soon -Kounteya Sinha&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India&lt;br /&gt;
&lt;br /&gt;
Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in the Drugs and Cosmetics Rules.&lt;br /&gt;
&lt;br /&gt;
Once notified, following clearance from the law ministry, these drugs cannot be sold without prescription.&lt;br /&gt;
&lt;br /&gt;
The drugs will also have to carry a prominent label in red colour on the left corner with the following warning: &amp;quot;It is dangerous to take this prescription except in accordance with medical advice and not to be sold by retail without the prescription of the registered medical practitioner.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Dr Singh said important drugs that Indians are becoming resistant to or can become resistant to are being put under schedule H1.&lt;br /&gt;
&lt;br /&gt;
He added, &amp;quot;These drugs will only be sold against a prescription that the chemist will have to retain. The label of these drugs will have to carry a special warning. I am instructing the state drug controller generals to be ready to conduct surprise check on compliance of retailers once H1 is notified.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
A Union health ministry official said, &amp;quot;The draft rules to amend the Drugs and Cosmetic Rules were earlier published. We will look at the public feedbacks as soon as the monsoon session in Parliament is over. We intend to notify H1 after the law ministry clears it.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Resistance to antibiotics is becoming a serious threat for India because of popular habit to pop pills at will.&lt;br /&gt;
&lt;br /&gt;
Even the World Health Organization (WHO) recently warned that the world is staring at a post-antibiotic era, when common infections will no longer have a cure.&lt;br /&gt;
&lt;br /&gt;
WHO director general Dr Margaret Chan had said, &amp;quot;The world is on the brink of losing these miracle cures.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Even director of Centres for Disease Control Atlanta chief Dr Thomas R Frieden, who was in India, told the TOI that drug resistance due to irrational use of antibiotics will increase in the future.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;It is very important that India came out with a policy to control irrational use of antibiotics. Superbugs like NDM1 and drug resistance are definitely major threats,&amp;quot; Dr Frieden had said.&lt;br /&gt;
&lt;br /&gt;
A recent study by the Centre for Disease Dynamics, Economics and Policy, Washington DC, said there has been a six-fold increase in the number of antibiotics being popped by Indians.&lt;br /&gt;
&lt;br /&gt;
This includes the retail sale of Carbapenems &amp;mdash; a powerful class IV antibiotics, typically used as a &amp;quot;last resort&amp;quot; to treat serious infections caused by multi-drug resistant, gram-negative pathogens.&lt;br /&gt;
&lt;br /&gt;
The CDDEP study said that retail sale of carbapenems increased six times &amp;mdash; from 0.21 units per million in 2005 to 1.23 in 2010 &amp;mdash; raising serious fears of resistance to these drugs.&lt;br /&gt;
&lt;br /&gt;
The Centre said that based on pharmaceutical audit data from IMS Health&#039;s Multinational Integrated Data Analysis System (MIDAS), the size of the carbapenem retail market in India was $27.4 million (Rs 119.4 crore) in 2010.&lt;br /&gt;
&lt;br /&gt;
The drugs to come under H1 includes Moxifloxacin, Meropenem, Imipenem, Ertapenem, Doripenem, Colistin, Linezolid, Cefpirome, Gentamicin, Amikacin, Pencillin, Oxacilin, Zolpidem, Cefalexin, Norfloxacin, Cefaclor, Cefdinir, Tigecycline, Tobramycin, Tramadol and Vancomycin.&lt;br /&gt;
&lt;br /&gt;
CDDEP says the highly competitive domestic pharmaceutical industry in India could play a role in the rapid growth of carbapenem overuse. Based on search of the CIMS, there are over 55 brand names of carbapenem antibiotics retailed on the Indian market.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;&amp;quot;This is a lot, considering carbapenems are a relatively new antibiotic class with only four drugs: meropenem (most popular in India), imipenem/cilastatin, ertapenem and doripenem (the newest and most expensive one). By comparison, there were only six product names in Pakistan and five in the US,&amp;quot; the study said.&lt;br /&gt;
&lt;br /&gt;
According to Chan, when antibiotics were first introduced in the 1940s, they were hailed as wonder drugs. &amp;quot;Widespread infections that killed millions could be cured. Major diseases, like syphilis, gonorrhea, leprosy and tuberculosis lost much of their sting,&amp;quot; she added.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 4 September, 2012, http://timesofindia.indiatimes.com/india/Curb-on-over-the-counter-sale-of-92-antibiotics-soon/articleshow/16241650.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;curb-on-over-the-counter-sale-of-92-antibiotics-soon-kounteya-sinha-16934&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 16934,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 16806
$metaTitle = &#039;LATEST NEWS UPDATES | Curb on over-the-counter sale of 92 antibiotics soon -Kounteya Sinha&#039;
$metaKeywords = &#039;medicines,Health&#039;
$metaDesc = &#039;
-The Times of India

Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;br /&gt;&lt;br /&gt;Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in the Drugs and Cosmetics Rules.&lt;br /&gt;&lt;br /&gt;Once notified, following clearance from the law ministry, these drugs cannot be sold without prescription.&lt;br /&gt;&lt;br /&gt;The drugs will also have to carry a prominent label in red colour on the left corner with the following warning: &amp;quot;It is dangerous to take this prescription except in accordance with medical advice and not to be sold by retail without the prescription of the registered medical practitioner.&amp;quot;&lt;br /&gt;&lt;br /&gt;Dr Singh said important drugs that Indians are becoming resistant to or can become resistant to are being put under schedule H1.&lt;br /&gt;&lt;br /&gt;He added, &amp;quot;These drugs will only be sold against a prescription that the chemist will have to retain. The label of these drugs will have to carry a special warning. I am instructing the state drug controller generals to be ready to conduct surprise check on compliance of retailers once H1 is notified.&amp;quot;&lt;br /&gt;&lt;br /&gt;A Union health ministry official said, &amp;quot;The draft rules to amend the Drugs and Cosmetic Rules were earlier published. We will look at the public feedbacks as soon as the monsoon session in Parliament is over. We intend to notify H1 after the law ministry clears it.&amp;quot;&lt;br /&gt;&lt;br /&gt;Resistance to antibiotics is becoming a serious threat for India because of popular habit to pop pills at will.&lt;br /&gt;&lt;br /&gt;Even the World Health Organization (WHO) recently warned that the world is staring at a post-antibiotic era, when common infections will no longer have a cure.&lt;br /&gt;&lt;br /&gt;WHO director general Dr Margaret Chan had said, &amp;quot;The world is on the brink of losing these miracle cures.&amp;quot;&lt;br /&gt;&lt;br /&gt;Even director of Centres for Disease Control Atlanta chief Dr Thomas R Frieden, who was in India, told the TOI that drug resistance due to irrational use of antibiotics will increase in the future.&lt;br /&gt;&lt;br /&gt;&amp;quot;It is very important that India came out with a policy to control irrational use of antibiotics. Superbugs like NDM1 and drug resistance are definitely major threats,&amp;quot; Dr Frieden had said.&lt;br /&gt;&lt;br /&gt;A recent study by the Centre for Disease Dynamics, Economics and Policy, Washington DC, said there has been a six-fold increase in the number of antibiotics being popped by Indians.&lt;br /&gt;&lt;br /&gt;This includes the retail sale of Carbapenems &amp;mdash; a powerful class IV antibiotics, typically used as a &amp;quot;last resort&amp;quot; to treat serious infections caused by multi-drug resistant, gram-negative pathogens.&lt;br /&gt;&lt;br /&gt;The CDDEP study said that retail sale of carbapenems increased six times &amp;mdash; from 0.21 units per million in 2005 to 1.23 in 2010 &amp;mdash; raising serious fears of resistance to these drugs.&lt;br /&gt;&lt;br /&gt;The Centre said that based on pharmaceutical audit data from IMS Health&#039;s Multinational Integrated Data Analysis System (MIDAS), the size of the carbapenem retail market in India was $27.4 million (Rs 119.4 crore) in 2010.&lt;br /&gt;&lt;br /&gt;The drugs to come under H1 includes Moxifloxacin, Meropenem, Imipenem, Ertapenem, Doripenem, Colistin, Linezolid, Cefpirome, Gentamicin, Amikacin, Pencillin, Oxacilin, Zolpidem, Cefalexin, Norfloxacin, Cefaclor, Cefdinir, Tigecycline, Tobramycin, Tramadol and Vancomycin.&lt;br /&gt;&lt;br /&gt;CDDEP says the highly competitive domestic pharmaceutical industry in India could play a role in the rapid growth of carbapenem overuse. Based on search of the CIMS, there are over 55 brand names of carbapenem antibiotics retailed on the Indian market.&lt;br /&gt;&lt;br /&gt;&amp;quot;&amp;quot;This is a lot, considering carbapenems are a relatively new antibiotic class with only four drugs: meropenem (most popular in India), imipenem/cilastatin, ertapenem and doripenem (the newest and most expensive one). By comparison, there were only six product names in Pakistan and five in the US,&amp;quot; the study said.&lt;br /&gt;&lt;br /&gt;According to Chan, when antibiotics were first introduced in the 1940s, they were hailed as wonder drugs. &amp;quot;Widespread infections that killed millions could be cured. Major diseases, like syphilis, gonorrhea, leprosy and tuberculosis lost much of their sting,&amp;quot; she added.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/curb-on-over-the-counter-sale-of-92-antibiotics-soon-kounteya-sinha-16934.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Curb on over-the-counter sale of 92 antibiotics soon -Kounteya Sinha | Im4change.org</title>
    <meta name="description" content="
-The Times of India

Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Curb on over-the-counter sale of 92 antibiotics soon -Kounteya Sinha</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India<br /><br />Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in the Drugs and Cosmetics Rules.<br /><br />Once notified, following clearance from the law ministry, these drugs cannot be sold without prescription.<br /><br />The drugs will also have to carry a prominent label in red colour on the left corner with the following warning: &quot;It is dangerous to take this prescription except in accordance with medical advice and not to be sold by retail without the prescription of the registered medical practitioner.&quot;<br /><br />Dr Singh said important drugs that Indians are becoming resistant to or can become resistant to are being put under schedule H1.<br /><br />He added, &quot;These drugs will only be sold against a prescription that the chemist will have to retain. The label of these drugs will have to carry a special warning. I am instructing the state drug controller generals to be ready to conduct surprise check on compliance of retailers once H1 is notified.&quot;<br /><br />A Union health ministry official said, &quot;The draft rules to amend the Drugs and Cosmetic Rules were earlier published. We will look at the public feedbacks as soon as the monsoon session in Parliament is over. We intend to notify H1 after the law ministry clears it.&quot;<br /><br />Resistance to antibiotics is becoming a serious threat for India because of popular habit to pop pills at will.<br /><br />Even the World Health Organization (WHO) recently warned that the world is staring at a post-antibiotic era, when common infections will no longer have a cure.<br /><br />WHO director general Dr Margaret Chan had said, &quot;The world is on the brink of losing these miracle cures.&quot;<br /><br />Even director of Centres for Disease Control Atlanta chief Dr Thomas R Frieden, who was in India, told the TOI that drug resistance due to irrational use of antibiotics will increase in the future.<br /><br />&quot;It is very important that India came out with a policy to control irrational use of antibiotics. Superbugs like NDM1 and drug resistance are definitely major threats,&quot; Dr Frieden had said.<br /><br />A recent study by the Centre for Disease Dynamics, Economics and Policy, Washington DC, said there has been a six-fold increase in the number of antibiotics being popped by Indians.<br /><br />This includes the retail sale of Carbapenems &mdash; a powerful class IV antibiotics, typically used as a &quot;last resort&quot; to treat serious infections caused by multi-drug resistant, gram-negative pathogens.<br /><br />The CDDEP study said that retail sale of carbapenems increased six times &mdash; from 0.21 units per million in 2005 to 1.23 in 2010 &mdash; raising serious fears of resistance to these drugs.<br /><br />The Centre said that based on pharmaceutical audit data from IMS Health's Multinational Integrated Data Analysis System (MIDAS), the size of the carbapenem retail market in India was $27.4 million (Rs 119.4 crore) in 2010.<br /><br />The drugs to come under H1 includes Moxifloxacin, Meropenem, Imipenem, Ertapenem, Doripenem, Colistin, Linezolid, Cefpirome, Gentamicin, Amikacin, Pencillin, Oxacilin, Zolpidem, Cefalexin, Norfloxacin, Cefaclor, Cefdinir, Tigecycline, Tobramycin, Tramadol and Vancomycin.<br /><br />CDDEP says the highly competitive domestic pharmaceutical industry in India could play a role in the rapid growth of carbapenem overuse. Based on search of the CIMS, there are over 55 brand names of carbapenem antibiotics retailed on the Indian market.<br /><br />&quot;&quot;This is a lot, considering carbapenems are a relatively new antibiotic class with only four drugs: meropenem (most popular in India), imipenem/cilastatin, ertapenem and doripenem (the newest and most expensive one). By comparison, there were only six product names in Pakistan and five in the US,&quot; the study said.<br /><br />According to Chan, when antibiotics were first introduced in the 1940s, they were hailed as wonder drugs. &quot;Widespread infections that killed millions could be cured. Major diseases, like syphilis, gonorrhea, leprosy and tuberculosis lost much of their sting,&quot; she added.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 16806,
		'title' => 'Curb on over-the-counter sale of 92 antibiotics soon -Kounteya Sinha',
		'subheading' => '',
		'description' => '<div align="justify">
-The Times of India<br />
<br />
Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in the Drugs and Cosmetics Rules.<br />
<br />
Once notified, following clearance from the law ministry, these drugs cannot be sold without prescription.<br />
<br />
The drugs will also have to carry a prominent label in red colour on the left corner with the following warning: &quot;It is dangerous to take this prescription except in accordance with medical advice and not to be sold by retail without the prescription of the registered medical practitioner.&quot;<br />
<br />
Dr Singh said important drugs that Indians are becoming resistant to or can become resistant to are being put under schedule H1.<br />
<br />
He added, &quot;These drugs will only be sold against a prescription that the chemist will have to retain. The label of these drugs will have to carry a special warning. I am instructing the state drug controller generals to be ready to conduct surprise check on compliance of retailers once H1 is notified.&quot;<br />
<br />
A Union health ministry official said, &quot;The draft rules to amend the Drugs and Cosmetic Rules were earlier published. We will look at the public feedbacks as soon as the monsoon session in Parliament is over. We intend to notify H1 after the law ministry clears it.&quot;<br />
<br />
Resistance to antibiotics is becoming a serious threat for India because of popular habit to pop pills at will.<br />
<br />
Even the World Health Organization (WHO) recently warned that the world is staring at a post-antibiotic era, when common infections will no longer have a cure.<br />
<br />
WHO director general Dr Margaret Chan had said, &quot;The world is on the brink of losing these miracle cures.&quot;<br />
<br />
Even director of Centres for Disease Control Atlanta chief Dr Thomas R Frieden, who was in India, told the TOI that drug resistance due to irrational use of antibiotics will increase in the future.<br />
<br />
&quot;It is very important that India came out with a policy to control irrational use of antibiotics. Superbugs like NDM1 and drug resistance are definitely major threats,&quot; Dr Frieden had said.<br />
<br />
A recent study by the Centre for Disease Dynamics, Economics and Policy, Washington DC, said there has been a six-fold increase in the number of antibiotics being popped by Indians.<br />
<br />
This includes the retail sale of Carbapenems &mdash; a powerful class IV antibiotics, typically used as a &quot;last resort&quot; to treat serious infections caused by multi-drug resistant, gram-negative pathogens.<br />
<br />
The CDDEP study said that retail sale of carbapenems increased six times &mdash; from 0.21 units per million in 2005 to 1.23 in 2010 &mdash; raising serious fears of resistance to these drugs.<br />
<br />
The Centre said that based on pharmaceutical audit data from IMS Health's Multinational Integrated Data Analysis System (MIDAS), the size of the carbapenem retail market in India was $27.4 million (Rs 119.4 crore) in 2010.<br />
<br />
The drugs to come under H1 includes Moxifloxacin, Meropenem, Imipenem, Ertapenem, Doripenem, Colistin, Linezolid, Cefpirome, Gentamicin, Amikacin, Pencillin, Oxacilin, Zolpidem, Cefalexin, Norfloxacin, Cefaclor, Cefdinir, Tigecycline, Tobramycin, Tramadol and Vancomycin.<br />
<br />
CDDEP says the highly competitive domestic pharmaceutical industry in India could play a role in the rapid growth of carbapenem overuse. Based on search of the CIMS, there are over 55 brand names of carbapenem antibiotics retailed on the Indian market.<br />
<br />
&quot;&quot;This is a lot, considering carbapenems are a relatively new antibiotic class with only four drugs: meropenem (most popular in India), imipenem/cilastatin, ertapenem and doripenem (the newest and most expensive one). By comparison, there were only six product names in Pakistan and five in the US,&quot; the study said.<br />
<br />
According to Chan, when antibiotics were first introduced in the 1940s, they were hailed as wonder drugs. &quot;Widespread infections that killed millions could be cured. Major diseases, like syphilis, gonorrhea, leprosy and tuberculosis lost much of their sting,&quot; she added.
</div>',
		'credit_writer' => 'The Times of India, 4 September, 2012, http://timesofindia.indiatimes.com/india/Curb-on-over-the-counter-sale-of-92-antibiotics-soon/articleshow/16241650.cms',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'curb-on-over-the-counter-sale-of-92-antibiotics-soon-kounteya-sinha-16934',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 16934,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 16806,
	'metaTitle' => 'LATEST NEWS UPDATES | Curb on over-the-counter sale of 92 antibiotics soon -Kounteya Sinha',
	'metaKeywords' => 'medicines,Health',
	'metaDesc' => '
-The Times of India

Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in...',
	'disp' => '<div align="justify">-The Times of India<br /><br />Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in the Drugs and Cosmetics Rules.<br /><br />Once notified, following clearance from the law ministry, these drugs cannot be sold without prescription.<br /><br />The drugs will also have to carry a prominent label in red colour on the left corner with the following warning: &quot;It is dangerous to take this prescription except in accordance with medical advice and not to be sold by retail without the prescription of the registered medical practitioner.&quot;<br /><br />Dr Singh said important drugs that Indians are becoming resistant to or can become resistant to are being put under schedule H1.<br /><br />He added, &quot;These drugs will only be sold against a prescription that the chemist will have to retain. The label of these drugs will have to carry a special warning. I am instructing the state drug controller generals to be ready to conduct surprise check on compliance of retailers once H1 is notified.&quot;<br /><br />A Union health ministry official said, &quot;The draft rules to amend the Drugs and Cosmetic Rules were earlier published. We will look at the public feedbacks as soon as the monsoon session in Parliament is over. We intend to notify H1 after the law ministry clears it.&quot;<br /><br />Resistance to antibiotics is becoming a serious threat for India because of popular habit to pop pills at will.<br /><br />Even the World Health Organization (WHO) recently warned that the world is staring at a post-antibiotic era, when common infections will no longer have a cure.<br /><br />WHO director general Dr Margaret Chan had said, &quot;The world is on the brink of losing these miracle cures.&quot;<br /><br />Even director of Centres for Disease Control Atlanta chief Dr Thomas R Frieden, who was in India, told the TOI that drug resistance due to irrational use of antibiotics will increase in the future.<br /><br />&quot;It is very important that India came out with a policy to control irrational use of antibiotics. Superbugs like NDM1 and drug resistance are definitely major threats,&quot; Dr Frieden had said.<br /><br />A recent study by the Centre for Disease Dynamics, Economics and Policy, Washington DC, said there has been a six-fold increase in the number of antibiotics being popped by Indians.<br /><br />This includes the retail sale of Carbapenems &mdash; a powerful class IV antibiotics, typically used as a &quot;last resort&quot; to treat serious infections caused by multi-drug resistant, gram-negative pathogens.<br /><br />The CDDEP study said that retail sale of carbapenems increased six times &mdash; from 0.21 units per million in 2005 to 1.23 in 2010 &mdash; raising serious fears of resistance to these drugs.<br /><br />The Centre said that based on pharmaceutical audit data from IMS Health's Multinational Integrated Data Analysis System (MIDAS), the size of the carbapenem retail market in India was $27.4 million (Rs 119.4 crore) in 2010.<br /><br />The drugs to come under H1 includes Moxifloxacin, Meropenem, Imipenem, Ertapenem, Doripenem, Colistin, Linezolid, Cefpirome, Gentamicin, Amikacin, Pencillin, Oxacilin, Zolpidem, Cefalexin, Norfloxacin, Cefaclor, Cefdinir, Tigecycline, Tobramycin, Tramadol and Vancomycin.<br /><br />CDDEP says the highly competitive domestic pharmaceutical industry in India could play a role in the rapid growth of carbapenem overuse. Based on search of the CIMS, there are over 55 brand names of carbapenem antibiotics retailed on the Indian market.<br /><br />&quot;&quot;This is a lot, considering carbapenems are a relatively new antibiotic class with only four drugs: meropenem (most popular in India), imipenem/cilastatin, ertapenem and doripenem (the newest and most expensive one). By comparison, there were only six product names in Pakistan and five in the US,&quot; the study said.<br /><br />According to Chan, when antibiotics were first introduced in the 1940s, they were hailed as wonder drugs. &quot;Widespread infections that killed millions could be cured. Major diseases, like syphilis, gonorrhea, leprosy and tuberculosis lost much of their sting,&quot; she added.</div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 16806,
	'title' => 'Curb on over-the-counter sale of 92 antibiotics soon -Kounteya Sinha',
	'subheading' => '',
	'description' => '<div align="justify">
-The Times of India<br />
<br />
Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in the Drugs and Cosmetics Rules.<br />
<br />
Once notified, following clearance from the law ministry, these drugs cannot be sold without prescription.<br />
<br />
The drugs will also have to carry a prominent label in red colour on the left corner with the following warning: &quot;It is dangerous to take this prescription except in accordance with medical advice and not to be sold by retail without the prescription of the registered medical practitioner.&quot;<br />
<br />
Dr Singh said important drugs that Indians are becoming resistant to or can become resistant to are being put under schedule H1.<br />
<br />
He added, &quot;These drugs will only be sold against a prescription that the chemist will have to retain. The label of these drugs will have to carry a special warning. I am instructing the state drug controller generals to be ready to conduct surprise check on compliance of retailers once H1 is notified.&quot;<br />
<br />
A Union health ministry official said, &quot;The draft rules to amend the Drugs and Cosmetic Rules were earlier published. We will look at the public feedbacks as soon as the monsoon session in Parliament is over. We intend to notify H1 after the law ministry clears it.&quot;<br />
<br />
Resistance to antibiotics is becoming a serious threat for India because of popular habit to pop pills at will.<br />
<br />
Even the World Health Organization (WHO) recently warned that the world is staring at a post-antibiotic era, when common infections will no longer have a cure.<br />
<br />
WHO director general Dr Margaret Chan had said, &quot;The world is on the brink of losing these miracle cures.&quot;<br />
<br />
Even director of Centres for Disease Control Atlanta chief Dr Thomas R Frieden, who was in India, told the TOI that drug resistance due to irrational use of antibiotics will increase in the future.<br />
<br />
&quot;It is very important that India came out with a policy to control irrational use of antibiotics. Superbugs like NDM1 and drug resistance are definitely major threats,&quot; Dr Frieden had said.<br />
<br />
A recent study by the Centre for Disease Dynamics, Economics and Policy, Washington DC, said there has been a six-fold increase in the number of antibiotics being popped by Indians.<br />
<br />
This includes the retail sale of Carbapenems &mdash; a powerful class IV antibiotics, typically used as a &quot;last resort&quot; to treat serious infections caused by multi-drug resistant, gram-negative pathogens.<br />
<br />
The CDDEP study said that retail sale of carbapenems increased six times &mdash; from 0.21 units per million in 2005 to 1.23 in 2010 &mdash; raising serious fears of resistance to these drugs.<br />
<br />
The Centre said that based on pharmaceutical audit data from IMS Health's Multinational Integrated Data Analysis System (MIDAS), the size of the carbapenem retail market in India was $27.4 million (Rs 119.4 crore) in 2010.<br />
<br />
The drugs to come under H1 includes Moxifloxacin, Meropenem, Imipenem, Ertapenem, Doripenem, Colistin, Linezolid, Cefpirome, Gentamicin, Amikacin, Pencillin, Oxacilin, Zolpidem, Cefalexin, Norfloxacin, Cefaclor, Cefdinir, Tigecycline, Tobramycin, Tramadol and Vancomycin.<br />
<br />
CDDEP says the highly competitive domestic pharmaceutical industry in India could play a role in the rapid growth of carbapenem overuse. Based on search of the CIMS, there are over 55 brand names of carbapenem antibiotics retailed on the Indian market.<br />
<br />
&quot;&quot;This is a lot, considering carbapenems are a relatively new antibiotic class with only four drugs: meropenem (most popular in India), imipenem/cilastatin, ertapenem and doripenem (the newest and most expensive one). By comparison, there were only six product names in Pakistan and five in the US,&quot; the study said.<br />
<br />
According to Chan, when antibiotics were first introduced in the 1940s, they were hailed as wonder drugs. &quot;Widespread infections that killed millions could be cured. Major diseases, like syphilis, gonorrhea, leprosy and tuberculosis lost much of their sting,&quot; she added.
</div>',
	'credit_writer' => 'The Times of India, 4 September, 2012, http://timesofindia.indiatimes.com/india/Curb-on-over-the-counter-sale-of-92-antibiotics-soon/articleshow/16241650.cms',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'curb-on-over-the-counter-sale-of-92-antibiotics-soon-kounteya-sinha-16934',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 16934,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 16806
$metaTitle = 'LATEST NEWS UPDATES | Curb on over-the-counter sale of 92 antibiotics soon -Kounteya Sinha'
$metaKeywords = 'medicines,Health'
$metaDesc = '
-The Times of India

Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in...'
$disp = '<div align="justify">-The Times of India<br /><br />Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in the Drugs and Cosmetics Rules.<br /><br />Once notified, following clearance from the law ministry, these drugs cannot be sold without prescription.<br /><br />The drugs will also have to carry a prominent label in red colour on the left corner with the following warning: &quot;It is dangerous to take this prescription except in accordance with medical advice and not to be sold by retail without the prescription of the registered medical practitioner.&quot;<br /><br />Dr Singh said important drugs that Indians are becoming resistant to or can become resistant to are being put under schedule H1.<br /><br />He added, &quot;These drugs will only be sold against a prescription that the chemist will have to retain. The label of these drugs will have to carry a special warning. I am instructing the state drug controller generals to be ready to conduct surprise check on compliance of retailers once H1 is notified.&quot;<br /><br />A Union health ministry official said, &quot;The draft rules to amend the Drugs and Cosmetic Rules were earlier published. We will look at the public feedbacks as soon as the monsoon session in Parliament is over. We intend to notify H1 after the law ministry clears it.&quot;<br /><br />Resistance to antibiotics is becoming a serious threat for India because of popular habit to pop pills at will.<br /><br />Even the World Health Organization (WHO) recently warned that the world is staring at a post-antibiotic era, when common infections will no longer have a cure.<br /><br />WHO director general Dr Margaret Chan had said, &quot;The world is on the brink of losing these miracle cures.&quot;<br /><br />Even director of Centres for Disease Control Atlanta chief Dr Thomas R Frieden, who was in India, told the TOI that drug resistance due to irrational use of antibiotics will increase in the future.<br /><br />&quot;It is very important that India came out with a policy to control irrational use of antibiotics. Superbugs like NDM1 and drug resistance are definitely major threats,&quot; Dr Frieden had said.<br /><br />A recent study by the Centre for Disease Dynamics, Economics and Policy, Washington DC, said there has been a six-fold increase in the number of antibiotics being popped by Indians.<br /><br />This includes the retail sale of Carbapenems &mdash; a powerful class IV antibiotics, typically used as a &quot;last resort&quot; to treat serious infections caused by multi-drug resistant, gram-negative pathogens.<br /><br />The CDDEP study said that retail sale of carbapenems increased six times &mdash; from 0.21 units per million in 2005 to 1.23 in 2010 &mdash; raising serious fears of resistance to these drugs.<br /><br />The Centre said that based on pharmaceutical audit data from IMS Health's Multinational Integrated Data Analysis System (MIDAS), the size of the carbapenem retail market in India was $27.4 million (Rs 119.4 crore) in 2010.<br /><br />The drugs to come under H1 includes Moxifloxacin, Meropenem, Imipenem, Ertapenem, Doripenem, Colistin, Linezolid, Cefpirome, Gentamicin, Amikacin, Pencillin, Oxacilin, Zolpidem, Cefalexin, Norfloxacin, Cefaclor, Cefdinir, Tigecycline, Tobramycin, Tramadol and Vancomycin.<br /><br />CDDEP says the highly competitive domestic pharmaceutical industry in India could play a role in the rapid growth of carbapenem overuse. Based on search of the CIMS, there are over 55 brand names of carbapenem antibiotics retailed on the Indian market.<br /><br />&quot;&quot;This is a lot, considering carbapenems are a relatively new antibiotic class with only four drugs: meropenem (most popular in India), imipenem/cilastatin, ertapenem and doripenem (the newest and most expensive one). By comparison, there were only six product names in Pakistan and five in the US,&quot; the study said.<br /><br />According to Chan, when antibiotics were first introduced in the 1940s, they were hailed as wonder drugs. &quot;Widespread infections that killed millions could be cured. Major diseases, like syphilis, gonorrhea, leprosy and tuberculosis lost much of their sting,&quot; she added.</div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Curb on over-the-counter sale of 92 antibiotics soon -Kounteya Sinha

-The Times of India Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in the Drugs and Cosmetics Rules. Once notified, following clearance from the law ministry, these drugs cannot be sold without prescription. The drugs will also have to carry a prominent label in red colour on the left corner with the following warning: "It is dangerous to take this prescription except in accordance with medical advice and not to be sold by retail without the prescription of the registered medical practitioner." Dr Singh said important drugs that Indians are becoming resistant to or can become resistant to are being put under schedule H1. He added, "These drugs will only be sold against a prescription that the chemist will have to retain. The label of these drugs will have to carry a special warning. I am instructing the state drug controller generals to be ready to conduct surprise check on compliance of retailers once H1 is notified." A Union health ministry official said, "The draft rules to amend the Drugs and Cosmetic Rules were earlier published. We will look at the public feedbacks as soon as the monsoon session in Parliament is over. We intend to notify H1 after the law ministry clears it." Resistance to antibiotics is becoming a serious threat for India because of popular habit to pop pills at will. Even the World Health Organization (WHO) recently warned that the world is staring at a post-antibiotic era, when common infections will no longer have a cure. WHO director general Dr Margaret Chan had said, "The world is on the brink of losing these miracle cures." Even director of Centres for Disease Control Atlanta chief Dr Thomas R Frieden, who was in India, told the TOI that drug resistance due to irrational use of antibiotics will increase in the future. "It is very important that India came out with a policy to control irrational use of antibiotics. Superbugs like NDM1 and drug resistance are definitely major threats," Dr Frieden had said. A recent study by the Centre for Disease Dynamics, Economics and Policy, Washington DC, said there has been a six-fold increase in the number of antibiotics being popped by Indians. This includes the retail sale of Carbapenems — a powerful class IV antibiotics, typically used as a "last resort" to treat serious infections caused by multi-drug resistant, gram-negative pathogens. The CDDEP study said that retail sale of carbapenems increased six times — from 0.21 units per million in 2005 to 1.23 in 2010 — raising serious fears of resistance to these drugs. The Centre said that based on pharmaceutical audit data from IMS Health's Multinational Integrated Data Analysis System (MIDAS), the size of the carbapenem retail market in India was $27.4 million (Rs 119.4 crore) in 2010. The drugs to come under H1 includes Moxifloxacin, Meropenem, Imipenem, Ertapenem, Doripenem, Colistin, Linezolid, Cefpirome, Gentamicin, Amikacin, Pencillin, Oxacilin, Zolpidem, Cefalexin, Norfloxacin, Cefaclor, Cefdinir, Tigecycline, Tobramycin, Tramadol and Vancomycin. CDDEP says the highly competitive domestic pharmaceutical industry in India could play a role in the rapid growth of carbapenem overuse. Based on search of the CIMS, there are over 55 brand names of carbapenem antibiotics retailed on the Indian market. ""This is a lot, considering carbapenems are a relatively new antibiotic class with only four drugs: meropenem (most popular in India), imipenem/cilastatin, ertapenem and doripenem (the newest and most expensive one). By comparison, there were only six product names in Pakistan and five in the US," the study said. According to Chan, when antibiotics were first introduced in the 1940s, they were hailed as wonder drugs. "Widespread infections that killed millions could be cured. Major diseases, like syphilis, gonorrhea, leprosy and tuberculosis lost much of their sting," she added.